Deka BioSciences, Inc. has announced that it has received $20 million in a series B2 round of funding led by new investor MPM Asset Management, L.L.C. on September 28, 2023. The transaction included participation from new investors i2E Management Company, Inc., Amana Investments Limited, Asset Management Arm, ATEM Capital, existing investors Lumira Ventures, Echo Investment S.A., Alexandria Venture Investments, LLC, Leaps by Bayer and Viva BioInnovator. John Mumm of the company also participated in the transaction.

As a part of transaction Detlev Biniszkiewicz of MPM-BioImpact will join the company's board of directors. The company has raised total of $55 million funding till date.